Merck unveils Phase 3 data for new peptide treatment

Traders Union
All News
Market Voices
Merck unveils peptide trial data

Top Stories

Editors' Picks

Stocks

Crypto

Financial News

Currencies

Commodities

Companies

Central Banks

Andrey Mastykin

08.11.2025

Merck unveils Phase 3 data for new peptide treatment — @Merck: Merck unveils peptide trial data

Merck has unveiled the first-time results of its Phase 3 study for an investigational oral macrocyclic peptide.

The announcement was made at the American Heart Association's annual event, AHA25, highlighting the potential impact of this innovative treatment. This phase marks a significant milestone in the development of new therapies and showcases Merck's commitment to advancing medical research. More detailed findings and implications can be explored through their online release.

Loading...

The tweet was deleted by the author.

But we saved everything 🙂.

Merck's latest findings add to a growing body of evidence supporting innovation within the pharmaceutical sector. Such breakthroughs build upon previous advancements, including the release of long-term data for lung cancer immunotherapy, which highlighted the company's broader approach to developing novel treatment modalities. Further context on this strategy can be found in the coverage of Merck’s immunotherapy data for non-small cell lung cancer.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.

Did you like the article?

Editor's Picks for You

CBDC ban: Why the U.S. does not need a digital dollar

By Eugene Komchuk
1 hour ago

CBDC ban: Why the U.S. does not need a digital dollar

Editors' Picks

Bitcoin price prediction and Bollinger Bands: Can BTC recover after falling to $63,000?

By Mikhail Vnuchkov
Yesterday

Bitcoin price prediction and Bollinger Bands: Can BTC recover after falling to $63,000?

Editors' Picks

FIFA World Cup on blockchain: Where football meets crypto

By Oleg Tkachenko
22.06.2026

FIFA World Cup on blockchain: Where football meets crypto

Editors' Picks

All Editors' Top Picks

Latest Merck News

Merck stock slides amid strong selling pressure despite Phase 3 immunology trial update

By Jose Antonio Gastelum
Yesterday

Merck stock slides amid strong selling pressure despite Phase 3 immunology trial update

Companies

Merck stock drops 1.25% as company posts strong Phase 3 HIV data with Gilead Sciences

By Ezequiel Gomes
09.06.2026

Merck stock drops 1.25% as company posts strong Phase 3 HIV data with Gilead Sciences

Companies

Merck stock price forecast: bullish bias and tight range as MRK holds near highs

By Jose Antonio Gastelum
13.04.2026

Merck stock price forecast: bullish bias and tight range as MRK holds near highs

Companies

Eugene Komchuk
1 hour ago

CBDC ban: Why the U.S. does not need a digital dollar

Mikhail Vnuchkov
Yesterday

Bitcoin price prediction and Bollinger Bands: Can BTC recover after falling to $63,000?

Oleg Tkachenko
22.06.2026

FIFA World Cup on blockchain: Where football meets crypto

Pavlo Kot
21.06.2026

Aliens, Satoshi, and Bitcoin: How the extraterrestrial theory emerged

Pavlo Kot
20.06.2026

Blockchain nation in crisis: How a power struggle split Liberland

Daria Chernytska
13 min ago

Liquidity test follows easy asset listing in tokenized markets, Gracy Chen notes

Dmytro Kharkov
14 min ago

Central bankers debate financial innovation at Zurich forum, Bilal bin Saqib notes

Artem Shendetskii
44 min ago

Mario Nawfal: Venezuela faces largest global debt restructuring with $240 billion obligation

Mikhail Vnuchkov
1 hour ago

Vedanta seeks $372 million from Zambia copper unit IPO, Tracy Shuchart reveals

Artem Shendetskii
2 hours ago

Awaits market reversal to build Cable position, Tom Dante notes

Weekly Top Bonuses

Capitalcore

up to $2,500
deposit bonus for all clients

Your capital is at risk.

Top News

Hanna Syniavska
11 min ago

Cboe enters prediction markets with Mini-S&P 500 contracts

Cboe enters prediction markets with Mini-S&P 500 contracts

Olga Shendetskaya
58 min ago

U.S. stock futures waver as doubts grow around AI trade

U.S. stock futures waver as doubts grow around AI trade

Ivan Andriyenko
1 hour ago

SoftBank seeks Tepco stake to power AI expansion

SoftBank seeks Tepco stake to power AI expansion

Ivan Andriyenko
2 hours ago

Oil drops as Trump presses companies over gasoline prices

Oil drops as Trump presses companies over gasoline prices

Ashutosh Sureka
11 hours ago

Senate Democrats seek hearings on Trump family crypto ties and Abu Dhabi investment

Senate Democrats seek hearings on Trump family crypto ties and Abu Dhabi investment

Top 5 companies for you

United States

Live News

Mykhailo Ihnatenko
Now

BT Group searches for growth amid fierce competition

Mykhailo Ihnatenko
Now

Ethereum remains under pressure as ETF outflows accelerate

Mykhailo Ihnatenko
Now

Bitcoin faces growing pressure amid weak institutional demand

Anton Kharitonov
Now

Goog;e pulls back as AI talent concerns pressure sentiment

Anton Kharitonov
Now

Apple pulls back below $300 as AI doubts offset strong fundamentals

© IAFT Ltd., 2010-2026 All rights to the website are owned by IAFT Ltd.,
Registration number - HE 336186

Risk disclosure:

Information on the TradersUnion.com website is for informational purposes only and does not constitute any motive or suggestion to visitors to invest money. Moreover, we hereby warn you that trading on the Forex and CFD markets is always a high risk. According to the statistics, 75-89% of customers lose the funds invested and only 11-25% of traders earn a profit. Trading in futures and options carries substantial risk of loss and is not suitable for every investor.

That is why you should only invest money that you are prepared — or can afford — to lose at such high risks. Tradersunion.com does not provide any financial services, including investment or financial advisory services. Also, the Traders Union is not a broker and does not get money for trading in the Forex or CFD markets. Our website only provides information on brokers and the markets and helps its users to select the best brokerage company based on detailed information and objective analysis of brokers.
Disclaimer:

Traders Union (TradersUnion.com) shall not be liable for the consequences of trading decisions made by the Client and for the possible loss of his capital resulting from the use of this website and information published on it.

Forex market, CFD and cryptocurrency trading involves high risks and is not suitable for everyone. Before investing money, you need to adequately assess the level of your expertise and be aware of the risks, particularly in the context of trading with leverage. The information on this website is not intended for distribution or use by any person in any country or jurisdiction, where such distribution or use would be in violation of the local law or regulation. Any payments by Traders Union (TradersUnion.com) to the users of our website shall be legally interpreted solely as an incentive on our part for the activity on the website in the form of a deduction of a part of the advertising income; they shall not be a subject of any claims of our users or our obligations, a subject of disputes, as well as cannot be considered in relation to the services provided to users by brokers, both in fact and in their completeness and volume. The administration of the website shall not be liable for the content of user comments and reviews about the companies and shall not verify whether the authors of the reviews are indeed real clients of a specific company. All reviews, both negative and positive are published on the website without verification of their reliability; only offensive reviews that call for violence or any kind of discrimination and also reviews published from one group of IP addresses are moderated and removed. The authors of the materials shall be fully liable for the accuracy, completeness and impartiality of any information in the articles and reviews, including in the context of their use or mention of any brand names or trademarks. All mentions of the names of companies and their brands in any materials on the website shall be made in the context of communication of socially important information to the people about their activities by independent journalists, who are the authors. All evaluations and indicators on the website express the subjective opinion of the authors of the reviews (articles) and shall not be viewed as accurate statements and be a subject of disputes and claims against Traders Union.
Disclosure of advertisers and revenues:

All the services on the Tradersunion.com website are free for you to use. Our team spends thousands of hours per annum researching brokers and gathering information about them to help investors all over the world to choose reliable companies and to avoid fraudsters.

Indeed, the curating, sourcing, and organization of this process requires substantial financial investment by Tradersunion.com, which the website earns in the form of advertising payments. There are two types of advertising services on the website — direct advertising or partner (broker) participation programs. However, no services purchased by our partners shall affect the recommendations on our website, or our opinions, or ratings. Our ratings are based on our objective rating criteria and methodology; and the results are always equally and fairly applied to each broker. The work of our content authors and research groups does not involve any interaction with our advertisers and they do not have access to data concerning the amount of advertising purchased. For over 10 years we consider our independence, absolute openness, and objectivity as our main priority. Please follow the links to each of our affiliated broker’s websites. This will help Tradersunion.com to continue to provide our services to you for free.